|
|
Gene Symbol |
IDE |
|
Aliases |
INSULYSIN |
|
Entrez Gene ID |
|
|
Gene Name |
Insulin degrading enzyme |
|
Chromosomal Location |
10q23.33 |
|
HGNC ID |
|
|
Summary |
This gene encodes a zinc metallopeptidase that degrades intracellular insulin, and thereby terminates insulins activity, as well as participating in intercellular peptide signalling by degrading diverse peptides such as glucagon, amylin, bradykinin, and kallidin. The preferential affinity of this enzyme for insulin results in insulin-mediated inhibition of the degradation of other peptides such as beta-amyloid. Deficiencies in this protein's function are associated with Alzheimer's disease and type 2 diabetes mellitus but mutations in this gene have not been shown to be causitive for these diseases. This protein localizes primarily to the cytoplasm but in some cell types localizes to the extracellular space, cell membrane, peroxisome, and mitochondrion. Alternative splicing results in multiple transcript variants encoding distinct isoforms. Additional transcript variants have been described but have not been experimentally verified.[provided by RefSeq, Sep 2009]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
SNPs
SNP Id |
Upstream Sequence |
SNP |
Downstream Sequence |
Functional Significance |
References |
rs2209972 |
GGACTGCAGGGCGCTCACGCTTGCTG |
C/T |
GAAGTAAGGCGTTTGAAGGTGAGGC |
Nc transcript variant |
17953957 | |
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0006508 |
Biological process |
Proteolysis |
IDA |
18602473, 20082125, 21185309 |
GO:0008286 |
Biological process |
Insulin receptor signaling pathway |
NAS |
3059494 |
GO:0008340 |
Biological process |
Determination of adult lifespan |
IDA |
18448515 |
GO:0010815 |
Biological process |
Bradykinin catabolic process |
IDA |
17613531, 21185309 |
GO:0010992 |
Biological process |
Ubiquitin recycling |
IDA |
21185309 |
GO:0019885 |
Biological process |
Antigen processing and presentation of endogenous peptide antigen via MHC class I |
IMP |
20364150 |
GO:0032461 |
Biological process |
Positive regulation of protein oligomerization |
IDA |
9830016 |
GO:0042447 |
Biological process |
Hormone catabolic process |
IBA |
21873635 |
GO:0042447 |
Biological process |
Hormone catabolic process |
IDA |
19321446 |
GO:0043171 |
Biological process |
Peptide catabolic process |
IDA |
20364150 |
GO:0044257 |
Biological process |
Cellular protein catabolic process |
IMP |
20364150 |
GO:0045732 |
Biological process |
Positive regulation of protein catabolic process |
TAS |
22383525 |
GO:0050435 |
Biological process |
Amyloid-beta metabolic process |
IBA |
21873635 |
GO:0050435 |
Biological process |
Amyloid-beta metabolic process |
IDA |
9830016, 17613531, 26968463 |
GO:0051260 |
Biological process |
Protein homooligomerization |
IDA |
17051221 |
GO:0051603 |
Biological process |
Proteolysis involved in cellular protein catabolic process |
IBA |
21873635 |
GO:0051603 |
Biological process |
Proteolysis involved in cellular protein catabolic process |
IDA |
9830016 |
GO:0097242 |
Biological process |
Amyloid-beta clearance |
IMP |
10684867, 16511862 |
GO:0150094 |
Biological process |
Amyloid-beta clearance by cellular catabolic process |
IMP |
23525105 |
GO:1901142 |
Biological process |
Insulin metabolic process |
IDA |
18448515 |
GO:1901143 |
Biological process |
Insulin catabolic process |
IDA |
9231799, 9830016, 19321446 |
GO:1903715 |
Biological process |
Regulation of aerobic respiration |
IGI |
23525105 |
GO:0005615 |
Cellular component |
Extracellular space |
IDA |
9830016 |
GO:0005615 |
Cellular component |
Extracellular space |
TAS |
10684867 |
GO:0005634 |
Cellular component |
Nucleus |
IDA |
9231799, 15285718 |
GO:0005634 |
Cellular component |
Nucleus |
IDA |
18226493 |
GO:0005737 |
Cellular component |
Cytoplasm |
IDA |
9231799, 9830016, 18226493, 23525105 |
GO:0005739 |
Cellular component |
Mitochondrion |
IBA |
21873635 |
GO:0005739 |
Cellular component |
Mitochondrion |
IDA |
15285718, 23525105 |
GO:0005777 |
Cellular component |
Peroxisome |
IDA |
9231799 |
GO:0005777 |
Cellular component |
Peroxisome |
TAS |
10684867 |
GO:0005782 |
Cellular component |
Peroxisomal matrix |
IBA |
21873635 |
GO:0005829 |
Cellular component |
Cytosol |
IDA |
9830016, 15285718, 20364150 |
GO:0005829 |
Cellular component |
Cytosol |
TAS |
10684867 |
GO:0009897 |
Cellular component |
External side of plasma membrane |
IDA |
16511862 |
GO:0009986 |
Cellular component |
Cell surface |
IDA |
16511862, 17055432 |
GO:0016323 |
Cellular component |
Basolateral plasma membrane |
IMP |
16511862 |
GO:0004175 |
Molecular function |
Endopeptidase activity |
IDA |
20364150 |
GO:0004222 |
Molecular function |
Metalloendopeptidase activity |
IDA |
17051221, 17613531 |
GO:0004222 |
Molecular function |
Metalloendopeptidase activity |
TAS |
10684867 |
GO:0005102 |
Molecular function |
Signaling receptor binding |
IPI |
20178365 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
17055432, 17715127, 20959807 |
GO:0005524 |
Molecular function |
ATP binding |
IDA |
17613531 |
GO:0008270 |
Molecular function |
Zinc ion binding |
IDA |
17613531, 19321446 |
GO:0042277 |
Molecular function |
Peptide binding |
IPI |
20082125 |
GO:0042803 |
Molecular function |
Protein homodimerization activity |
IDA |
17613531, 19321446 |
GO:0043559 |
Molecular function |
Insulin binding |
IDA |
17051221 |
GO:0043559 |
Molecular function |
Insulin binding |
IPI |
20082125 |
GO:0140036 |
Molecular function |
Ubiquitin-dependent protein binding |
IPI |
21185309 |
|
Protein Information |
|
Protein Name |
Insulin-degrading enzyme, Abeta-degrading protease, insulin protease, insulinase |
|
Function |
Plays a role in the cellular breakdown of insulin, APP peptides, IAPP peptides, glucagon, bradykinin, kallidin and other peptides, and thereby plays a role in intercellular peptide signaling (PubMed:2293021, PubMed:10684867, PubMed:26968463, PubMed:17051221, PubMed:17613531, PubMed:18986166, PubMed:19321446, PubMed:23922390, PubMed:24847884, PubMed:26394692, PubMed:29596046). Substrate binding induces important conformation changes, making it possible to bind and degrade larger substrates, such as insulin (PubMed:23922390, PubMed:26394692, PubMed:29596046). Contributes to the regulation of peptide hormone signaling cascades and regulation of blood glucose homeostasis via its role in the degradation of insulin, glucagon and IAPP (By similarity). Plays a role in the degradation and clearance of APP-derived amyloidogenic peptides that are secreted by neurons and microglia (PubMed:9830016, PubMed:26394692) (Probable). Involved in antigen processing. Produces both the N terminus and the C terminus of MAGEA3-derived antigenic peptide (EVDPIGHLY) that is presented to cytotoxic T lymphocytes by MHC class I. .; (Microbial infection) The membrane-associated isoform acts as an entry receptor for varicella-zoster virus (VZV). |
|
|
|
|
|
UniProt |
|
|
PDB |
2G47, 2WK3, 4M1C, 3N56, 3N57, 3H44, 4RAL, 2G49, 6EDS, 2G48, 3HGZ, 2G54, 2G56, 2JBU, 2JG4, 2WBY, 2WC0, 2YPU, 3CWW, 3E4A, 3E4Z, 3E50, 3OFI, 3QZ2, 4DTT, 4DWK, 4GS8, 4GSC, 4GSF, 4IFH, 4IOF, 4LTE, 4NXO, 4PES, 4PF7, 4PF9, 4PFC, 4QIA, 4RE9, 5CJO, 5UOE, 5WOB, 6B3Q, 6B70, 6B7Y, 6B7Z, 6BF6, 6BF7, 6BF8, 6BF9, 6BFC, |
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000287936 |
|
P04035 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Endocrine System Diseases |
Diabetes Mellitus |
|
PCOS |
|
Nervous System Diseases |
Lateral Sclerosis |
|
Nutritional and Metabolic Diseases |
Gluocose Intolerance |
|
Psychiatric/Brain disorders |
Senile Dementia |
|
Alzheimer Disease |
|
Schizophrenia |
|
|
References |
|
|
Wang Kehua, You Li, Shi Yuhua, Wang Laicheng, Zhang Meixin, Chen Zi-Jiang |
Center for Reproductive Medicine, Shandong Provincial Hospital, Shandong University, Jinan, the People's Republic of China. |
Fertil Steril. 2008 Aug;90(2):378-84. doi: 10.1016/j.fertnstert.2007.06.016. Epub |
Abstract
OBJECTIVE: To evaluate the influence of the four single nucleotide polymorphisms of the insulin-degrading enzyme (IDE) gene on metabolic features in women with polycystic ovary syndrome (PCOS) in a Chinese population. DESIGN: Prospective, case-control study. SETTING: University-based hospital. PATIENT(S): Three hundred fifteen patients with PCOS and 327 healthy controls. INTERVENTION(S): Peripheral venous puncture, ultrasonography, oral glucose tolerance test (OGTT). MAIN OUTCOME MEASURE(S): Genotype analysis of four single nucleotide polymorphisms in the IDE gene, hormonal and metabolic phenotypes. RESULT(S): No significant differences in genotypes of these polymorphisms were found between PCOS patients and healthy controls. But the frequency of the C allele of rs2209972 was significantly higher in the PCOS group than that in the control group. The single nucleotide polymorphisms rs4646953, rs1887922, and rs1544210 had no impact on clinical and biochemical characteristics of women with PCOS. There were significant differences in body mass index (BMI) and insulin level in the rs2209972 genotype of women with PCOS. The women with PCOS with the CC genotype of rs2209972 had statistically significantly higher fasting insulin level and homeostasis model assessment for insulin resistance than the women with PCOS with the TT genotype. CONCLUSION(S): The single nucleotide polymorphism rs2209972 in the human IDE gene is associated with metabolic features of PCOS women in a Chinese population. |
|
|
|
|
| © 2019, Biomedical Informatics Centre, NIRRH |
National Institute for Research in Reproductive Health, Jehangir Merwanji Street, Parel, Mumbai-400 012
Tel: 91-22-24192104, Fax No: 91-22-24139412
|